• Combined treatment with naloxone and the alpha2 adrenoceptor antagonist atipamezole reversed brain hypoxia induced by a fentanyl-xylazine mixture in a rat model
  Published on 2023-12-19
  2 years ago
• TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner
  Published on 2023-12-18
  2 years ago
• Methylphenidate with or without fluoxetine triggers reinstatement of cocaine seeking behavior in rats
  Published on 2023-12-11
  2 years ago
• A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
  Published on 2023-12-11
  2 years ago
• IN MEMORIAM: Roland R. Griffiths, Ph.D
  Published on 2023-12-10
  2 years ago
• Factors influencing JUUL e-cigarette nicotine vapour-induced reward, withdrawal, pharmacokinetics and brain connectivity in rats: sex matters
  Published on 2023-12-06
  2 years ago
• Targeting SIK3 to modulate hippocampal synaptic plasticity and cognitive function by regulating the transcription of HDAC4 in a mouse model of Alzheimer’s disease
  Published on 2023-12-05
  2 years ago

« Previous 1 … 72 73 74 75 76 … 143 Next »

• Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro
  Published on 2021-10-27
  4 years ago
• Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial
  Published on 2021-10-26
  4 years ago
• Relationship between depression, prefrontal creatine and grey matter volume
  Published on 2021-10-26
  4 years ago
• Intoxication without anticipation: Disentangling pharmacological from expected effects of alcohol
  Published on 2021-10-25
  4 years ago
• Aberrant inhibitory processing in the somatosensory cortices of cannabis-users
  Published on 2021-10-25
  4 years ago
• Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats
  Published on 2021-10-25
  4 years ago
• Neuropsychological performance in young adults with cannabis use disorder
  Published on 2021-10-25
  4 years ago

« Previous 1 … 72 73 74 75 76 … 134 Next »

• The time to act: early recommendations on patient care for psychiatric disorders in post-acute COVID-19 syndrome (PDPACS); Response to Llach and Ammella´s letter to the editor (Llach and Anmella 2022)
  Published on 2022-05-21
  4 years ago
• Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder
  Published on 2022-05-11
  4 years ago
• Social Stress in Bipolar Disorder
  Published on 2022-05-11
  4 years ago
• Comparative studies of psychotropic drug use over the last seven decades: Gaps and goals in global ethnopsychopharmacology
  Published on 2022-05-11
  4 years ago
• Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials – Challenges and future perspectives. A critical review
  Published on 2022-05-11
  4 years ago
• Letter to the editor about the article “Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals” (Falconi A et al., 2022)
  Published on 2022-05-10
  4 years ago
• Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
  Published on 2022-05-10
  4 years ago

« Previous 1 … 72 73 74 75 76 … 154 Next »